Dr. Martens has announced the appointment of Giles Wilson as Chief Financial Officer, effective May 27, 2024, marking a significant addition to both the business and its board. Wilson will take the helm in presenting the FY24 results on May 30, 2024.
In a further show of confidence, Dr. Martens disclosed that Giles Wilson and Katie Wilson, closely associated individuals, have collectively acquired 57,400 shares in Dr. Martens plc on the open market since his appointment was first revealed.
Reflecting on his appointment last November, Wilson expressed his admiration for the iconic Dr. Martens brand and his excitement to contribute to the company’s growth trajectory. He lauded the passion and ambition within the organization, expressing eagerness to collaborate with CEO Kenny and the team to propel the company’s strategy forward.
Wilson brings a wealth of experience from his prior role as CFO at global spirit company William Grant & Sons Limited. Prior to his tenure at William Grant & Sons Limited, Wilson served as CFO at John Menzies Plc from 2016 to 2020, a prominent aviation services business, where he later assumed the role of CEO from 2019 to 2020.
Have you read?
20 US Cities that Offer the Best Value for your Social Security Income.
Revealed: These are the 25 Modern Inventions we really Don’t Use Anymore.
Richest Billionaire Investors In The World, 2024.
Ranked: Canada’s top 100 highest-paid CEOs, 2024.
Revealed: These Are The Richest People in Africa, 2024.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
